Back

Associations of fat and muscle mass indices with incident atrial fibrillation: data of PREVEND

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: diagnostic - clinical Prevention EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Assistant Professor Navin Suthahar

Erasmus University Medical Centre, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Risk of death, thrombotic and hemorrhagic events in patients with atrial fibrillation and systemic autoimmune diseases
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Atrial high-rate episodes detected by cardiac implantable electronic devices: arrhythmic burden and progression towards de-novo clinical atrial fibrillation
Doctor J. Imberti (Modena, IT)
Abstract Slides Video
Presentation thumbnail
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project
Doctor J. Vogler (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study)
Doctor V. Kanthasamy (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: diagnostic - clinical

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Spatial relationship between left peri-atrial fat with underlying arrhythmogenic substrate in patients with atrial fibrillation - innocent bystander or culprit?
thumbnail
Congress Presentation
Does a higher body mass index influence additional presence of low voltage areas in the left atrium in patients with persistent atrial fibrillation?
thumbnail
Congress Presentation
Associations between atrial epicardial fat quantified by semi-automated CT segmentation and gender, BMI, cholesterol levels in AF patients: results from the prospective AFAT study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources